Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Teva earnings: Facing down cheaper generic prices, generic competition of its own and a lot of debt
Teva earnings: Facing down cheaper generic prices, generic competition of its own and a lot of debt
Teva earnings: Facing down cheaper generic prices, generic competition of its own and a lot of debt
Submitted by
admin
on November 1, 2017 - 9:38am
Source:
Marketwatch
News Tags:
Teva Pharmaceutical
earnings
Headline:
Teva earnings: Facing down cheaper generic prices, generic competition of its own and a lot of debt
Do Not Allow Advertisers to Use My Personal information
